Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7TXT

Structure of human serotonin transporter bound to small molecule '8090 in lipid nanodisc and NaCl

Summary for 7TXT
Entry DOI10.2210/pdb7txt/pdb
EMDB information26160
Descriptor15B8 Fab heavy chain, 15B8 Fab light chain, Sodium-dependent serotonin transporter, ... (4 entities in total)
Functional Keywordsneurotransmitter transporter, small molecule, membrane protein, transport protein
Biological sourceMus musculus
More
Total number of polymer chains3
Total formula weight86397.45
Authors
Primary citationSingh, I.,Seth, A.,Billesbolle, C.B.,Braz, J.,Rodriguiz, R.M.,Roy, K.,Bekele, B.,Craik, V.,Huang, X.P.,Boytsov, D.,Pogorelov, V.M.,Lak, P.,O'Donnell, H.,Sandtner, W.,Irwin, J.J.,Roth, B.L.,Basbaum, A.I.,Wetsel, W.C.,Manglik, A.,Shoichet, B.K.,Rudnick, G.
Structure-based discovery of conformationally selective inhibitors of the serotonin transporter.
Cell, 186:2160-2175.e17, 2023
Cited by
PubMed Abstract: The serotonin transporter (SERT) removes synaptic serotonin and is the target of anti-depressant drugs. SERT adopts three conformations: outward-open, occluded, and inward-open. All known inhibitors target the outward-open state except ibogaine, which has unusual anti-depressant and substance-withdrawal effects, and stabilizes the inward-open conformation. Unfortunately, ibogaine's promiscuity and cardiotoxicity limit the understanding of inward-open state ligands. We docked over 200 million small molecules against the inward-open state of the SERT. Thirty-six top-ranking compounds were synthesized, and thirteen inhibited; further structure-based optimization led to the selection of two potent (low nanomolar) inhibitors. These stabilized an outward-closed state of the SERT with little activity against common off-targets. A cryo-EM structure of one of these bound to the SERT confirmed the predicted geometry. In mouse behavioral assays, both compounds had anxiolytic- and anti-depressant-like activity, with potencies up to 200-fold better than fluoxetine (Prozac), and one substantially reversed morphine withdrawal effects.
PubMed: 37137306
DOI: 10.1016/j.cell.2023.04.010
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon